IP Research Analyst
HalbornFull Time
Junior (1 to 2 years)
New York, New York, United States
Key technologies and capabilities for this role
Common questions about this position
Employee compensation includes bonus and equity compensation, in addition to generous benefit programs such as a 401k plan with company matching, and medical, dental, and vision insurance with premiums covered by Eikon at 95%.
This information is not specified in the job description.
Candidates need extensive experience in cell culture techniques including primary neuronal cultures, iPSC maintenance, and neuronal differentiation, plus proficiency in molecular biology and biochemical assays such as Western analysis, qRT-PCR, IPs, and ELISAs. A Bachelor’s degree with 6+ years or Master’s with 4+ years of experience in Neuroscience, Stem Cell Biology, or related field is required, along with excellent communication skills and organizational abilities.
The role emphasizes a collaborative, team-oriented mindset, upholding a culture of safety by adhering to laboratory protocols, and maintaining organized records in adherence to company standards.
Strong candidates have a Bachelor’s or Master’s in Neuroscience or Stem Cell Biology with the required years of experience, extensive hands-on expertise in iPSC differentiation, neuronal cultures, and biochemical assays, plus a detail-oriented, collaborative approach to troubleshooting and lab operations.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.